Cameron Reynolds

Cameron Reynolds has experience in management, structuring and strategic planning for companies, along with 25 years of entrepreneurial executive experience. Mr Reynolds is the President, chief executive and director of VolitionRX, a biotech company which listed on the New York Stock Exchange in February 2015 after being founded by Mr Reynolds in 2010. He has experience in the management, structuring and strategic planning of startup companies, and in the course of his career has held positions including chief executive, chief financial officer and non-executive director spanning various sectors in public and private enterprises.